Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Preclinical results with L-methioninase presented at cancer meeting

Oct. 23, 1997

Antiproliferative quinazoline derivatives disclosed at Zeneca

Oct. 23, 1997

NeoPharm moves LED to phase I for prostate cancer

Oct. 22, 1997

Pharmacyclics enters into licensing agreement with Nycomed for Lu-Tex

Oct. 21, 1997

Potential new anticancer vaccines described

Oct. 21, 1997

Yale-Vion developing bacteria-based cancer treatment

Oct. 21, 1997

Peptech reaches phase I goals for antagonist G; exercises license option

Oct. 20, 1997

ImClone and CombiChem enter alliance for drug discovery in oncology

Oct. 20, 1997

Agouron to collaborate with U.K. organizations in search for anticancer drugs

Oct. 17, 1997

Health Research claims peptide inhibitor of growth factors

Oct. 17, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
ADEL wins $1.04B Sanofi deal for tau-targeting Alzheimer’s drug
BioWorld
ADEL Inc. closed a year-end licensing deal worth up to $1.04 billion with Sanofi SA for ADEL-Y01, a specific tau-targeting Alzheimer’s disease drug candidate in a...